Insider Transactions Reported by 23 Insiders of Aclaris Therapeutics, Inc.

Symbol
ACRS on Nasdaq
Location
Wayne, PA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Aclaris Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Braden M. Leonard 10%+ Owner $17,731,275 02 Aug 2024
Neal Walker CEO, Director $5,376,123 03 Feb 2026
Anand Mehra Director $1,098,616 05 Jun 2025
Andrew N. Schiff Director $691,011 05 Jun 2025
Joseph Monahan Chief Scientific Officer $550,792 01 Mar 2025
Kevin Balthaser Chief Financial Officer $542,716 01 Mar 2026
James Loerop Chief Business Officer $461,957 03 Feb 2026
Hugh M. Davis President and COO, Director $321,944 03 Feb 2026
Frank Ruffo Chief Financial Officer $211,977 10 Mar 2022
Kamil Ali-Jackson Chief Legal Officer $168,225 03 Jan 2022
David N. Gordon Chief Medical Officer $154,819 13 Jul 2021
Douglas J. Manion Pres and CEO, Director $128,954 01 Jan 2024
Christopher P. Molineaux Director $93,609 05 Jun 2025
Gail Cawkwell Chief Medical Officer $57,323 01 Jul 2023
William D. Humphries Director $56,230 05 Jun 2025
Andrew Kenneth William Powell Director $42,239 01 Jun 2024
Maxine Gowen Director $38,220 05 Jun 2025
Bryan M. Reasons Director $36,202 01 Jun 2024
Vincent Milano Director $31,430 05 Jun 2025
Foresite Capital Management III, LLC 10%+ Owner $8,690 01 Nov 2021
Jesse Wayne Hall Chief Medical Officer 02 Feb 2026
Biosion, Inc. 10%+ Owner 18 Nov 2024
Roland Wilhelm Kolbeck Chief Scientific Officer 02 Feb 2026

Recent Insider Transactions by Companies or Individuals for Aclaris Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Kevin Balthaser ACRS Common Stock Tax liability -0.36% -677 187,453 01 Mar 2026 Direct
Kevin Balthaser ACRS Common Stock Options Exercise 1.28% 2,375 188,130 01 Mar 2026 Direct
Kevin Balthaser ACRS Restricted Stock Units Options Exercise -100% -2,375 0 01 Mar 2026 Direct
Hugh M. Davis ACRS Common Stock Options Exercise 69.8% 18,675 45,425 03 Feb 2026 Direct
Hugh M. Davis ACRS Restricted Stock Units Options Exercise -25% -18,675 56,025 03 Feb 2026 Direct
Kevin Balthaser ACRS Common Stock Tax liability -3.36% -6,449 185,755 03 Feb 2026 Direct
Kevin Balthaser ACRS Common Stock Options Exercise 12.9% 22,025 192,204 03 Feb 2026 Direct
Kevin Balthaser ACRS Restricted Stock Units Options Exercise -25% -22,025 66,075 03 Feb 2026 Direct
James Loerop ACRS Common Stock Tax liability -3% -5,937 192,260 03 Feb 2026 Direct
James Loerop ACRS Common Stock Options Exercise 11.8% 20,875 198,197 03 Feb 2026 Direct
James Loerop ACRS Restricted Stock Units Options Exercise -25% -20,875 62,625 03 Feb 2026 Direct
Neal Walker ACRS Common Stock Tax liability -1.19% -18,611 1,543,886 03 Feb 2026 Direct
Neal Walker ACRS Common Stock Options Exercise 4.23% 63,475 1,562,497 03 Feb 2026 Direct
Neal Walker ACRS Restricted Stock Units Options Exercise -25% -63,475 190,425 03 Feb 2026 Direct
Neal Walker ACRS Employee Stock Option (Right to Buy) Award 961,700 961,700 02 Feb 2026 Direct
Neal Walker ACRS Restricted Stock Units Award 274,800 274,800 02 Feb 2026 Direct
Hugh M. Davis ACRS Employee Stock Option (Right to Buy) Award 336,300 336,300 02 Feb 2026 Direct
Hugh M. Davis ACRS Restricted Stock Units Award 96,100 96,100 02 Feb 2026 Direct
Roland Wilhelm Kolbeck ACRS Employee Stock Option (Right to Buy) Award 334,900 334,900 02 Feb 2026 Direct
Roland Wilhelm Kolbeck ACRS Restricted Stock Units Award 95,700 95,700 02 Feb 2026 Direct
Jesse Wayne Hall ACRS Employee Stock Option (Right to Buy) Award 343,300 343,300 02 Feb 2026 Direct
Jesse Wayne Hall ACRS Restricted Stock Units Award 98,100 98,100 02 Feb 2026 Direct
James Loerop ACRS Employee Stock Option (Right to Buy) Award 341,900 341,900 02 Feb 2026 Direct
James Loerop ACRS Restricted Stock Units Award 97,700 97,700 02 Feb 2026 Direct
Kevin Balthaser ACRS Employee Stock Option (Right to Buy) Award 346,800 346,800 02 Feb 2026 Direct
Kevin Balthaser ACRS Restricted Stock Units Award 99,100 99,100 02 Feb 2026 Direct
Kevin Balthaser ACRS Common Stock Tax liability -2.85% -4,984 170,179 01 Feb 2026 Direct
Kevin Balthaser ACRS Common Stock Options Exercise 9.2% 14,750 175,163 01 Feb 2026 Direct
Kevin Balthaser ACRS Restricted Stock Units Options Exercise -33.3% -14,750 29,500 01 Feb 2026 Direct
James Loerop ACRS Common Stock Tax liability -5.68% -10,686 177,322 01 Feb 2026 Direct
James Loerop ACRS Common Stock Options Exercise 21.7% 33,500 188,008 01 Feb 2026 Direct
James Loerop ACRS Resticted Stock Units Options Exercise -50% -7,500 7,500 01 Feb 2026 Direct
James Loerop ACRS Restricted Stock Units Options Exercise -100% -26,000 0 01 Feb 2026 Direct
Neal Walker ACRS Common Stock Tax liability -0.66% -9,952 1,499,022 02 Jan 2026 Direct
Neal Walker ACRS Common Stock Options Exercise 1.97% 29,150 1,508,974 02 Jan 2026 Direct
Neal Walker ACRS Restricted Stock Units Options Exercise -49.2% -29,150 30,034 02 Jan 2026 Direct
James Loerop ACRS Common Stock Tax liability -3.83% -6,171 155,041 02 Jan 2026 Direct
James Loerop ACRS Common Stock Options Exercise 12.7% 18,150 161,212 02 Jan 2026 Direct
James Loerop ACRS Restricted Stock Units Options Exercise -49.2% -18,150 18,700 02 Jan 2026 Direct
Kevin Balthaser ACRS Common Stock Tax liability -2.71% -4,461 160,413 02 Jan 2026 Direct
Kevin Balthaser ACRS Common Stock Options Exercise 8.7% 13,200 164,874 02 Jan 2026 Direct
Kevin Balthaser ACRS Restricted Stock Units Options Exercise -49.2% -13,200 13,600 02 Jan 2026 Direct
Kevin Balthaser ACRS Common Stock Tax liability -1.46% -2,250 151,674 01 Jan 2026 Direct
Kevin Balthaser ACRS Common Stock Options Exercise 5.12% 7,500 153,924 01 Jan 2026 Direct
Kevin Balthaser ACRS Restricted Stock Units Options Exercise -50% -7,500 7,500 01 Jan 2026 Direct
James Loerop ACRS Common Stock Tax liability -19.2% -33,994 143,062 31 Dec 2025 Direct
James Loerop ACRS Common Stock Options Exercise 71.4% 73,750 177,056 31 Dec 2025 Direct
James Loerop ACRS Restricted Stock Units Options Exercise -100% -73,750 0 31 Dec 2025 Direct
Kevin Balthaser ACRS Common Stock Tax liability -12% -19,934 146,424 31 Dec 2025 Direct
Kevin Balthaser ACRS Common Stock Options Exercise 79.6% 73,750 166,358 31 Dec 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.